Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

No quotes available
-- EUR   0.00%
05/20 3SBIO INC. : (01530) withdraws breast cancer drug application
03/04 3SBIO : Bought CNY3.9bn Shares in CPGJ
03/04 3SBIO : adds stake in CP Guojian Pharma at Rmb3.9bn
SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M CNY Estimates in M CNY
Fiscal Period December 201320142015201620172018
Sales--1 6732 7583 4094 210
Operating income (EBITDA)--6921 0911 3751 592
Operating profit (EBIT)--6149191 1551 350
Pre-Tax Profit (EBT)------
Net income--5267839911 256
P/E ratio--39,619,615,111,8
EPS ( CNY )--0,230,310,410,52
Dividend per Share ( CNY )----0,010,01
Yield----0,11%0,16%
Reference price ( CNY )9.116.135176.135176.13517
Announcement Date--03/31/2016
11:12am
---
Finances - Leverage
Actuals in M CNY Estimates in M CNY
Fiscal Period December 201320142015201620172018
Debt---85283,0-
Finance--894--913
Operating income (EBITDA)--6921 0911 3751 592
Leverage
(Debt/EBITDA)
---0,78x0,06x-
Capital Expenditure--61,0124129108
Book Value Per Share (BVPS)---2,36  CNY2,75  CNY3,46  CNY
Cash Flow per Share--0,20  CNY0,36  CNY0,35  CNY0,57  CNY
Announcement Date01/01/1970
01:00am
01/01/1970
01:00am
03/31/2016
11:12am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 15 432 M CNY -
Entreprise Value (EV) 16 284 M CNY 15 515 M CNY
Valuation 2016e 2017e
P/E ratio (Price / EPS) 19,6x 15,1x
Capitalization / Revenue 5,59x 4,53x
EV / Revenue 5,90x 4,55x
EV / EBITDA 14,9x 11,3x
Yield (DPS / Price) - 0,11%
Price to book (Price / BVPS) 2,60x 2,23x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 33,3% 33,9%
operating Leverage (Delta EBIT / Delta Sales) 0,76x 1,09x
Net Margin (Net Profit / Revenue) 28,4% 29,1%
ROA (Net Profit / Asset) 9,39% 9,77%
ROE (Net Profit / Equities) 12,7% 14,7%
Rate of Dividend - 1,65%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   4,50% 3,78%
Cash Flow / Sales 32,5% 26,1%
Capital Intensity (Assets / Sales) 3,02x 2,98x
Financial Leverage (Net Debt / EBITDA) 0,78x 0,06x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend